KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 2 filers reported holding KYMERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,108,269 | -52.9% | 655,227 | -22.1% | 0.00% | -50.0% |
| Q2 2023 | $19,332,261 | -11.8% | 840,938 | +13.6% | 0.01% | -14.3% |
| Q1 2023 | $21,924,860 | +280376.7% | 739,991 | +136.3% | 0.01% | +250.0% |
| Q4 2022 | $7,817 | -99.8% | 313,160 | +47.5% | 0.00% | 0.0% |
| Q3 2022 | $4,624,000 | +25.4% | 212,365 | +13.4% | 0.00% | +100.0% |
| Q2 2022 | $3,687,000 | -63.3% | 187,281 | -21.2% | 0.00% | -66.7% |
| Q1 2022 | $10,060,000 | +144.2% | 237,731 | +266.3% | 0.00% | +200.0% |
| Q4 2021 | $4,120,000 | – | 64,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |